V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20105540 | 20087152 | 1.6 | 60 | Palliative (P) | null | 2018-04-27 | ARISTOTLE TRIAL | N | N | ECARBOX | 100202902 |
| 20105807 | 20087154 | 1.7 | 62.4 | Adjuvant (A) | 2019-11-04 | 2019-11-11 | Fluorouracil + Folinic + RT Bossett | 02 | N | SCOPE2 TRIAL | 100908438 |
| 20105865 | 20087155 | 0 | 0 | Palliative (P) | 2018-01-20 | 2018-01-20 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 01 | N | GEMCITABINE + PACLITAXEL | 100094039 |
| 20106119 | 20087156 | 1.65 | 85.7 | 03 | 2016-08-20 | 2016-08-20 | Bendamustine+Rituximab (1st Course) | 02 | N | ESPAC TRIAL | 101121579 |
| 20106217 | 20087158 | 1.6 | 78.3 | 03 | 2018-03-27 | 2018-04-03 | Gemcitabine + Paclitaxel | N | N | ABVD | 101224729 |
| 20106237 | 20087159 | 1.6 | 73.9 | 03 | 2017-04-14 | 2017-04-28 | CHOP R | 02 | N | SCOPE2 TRIAL | 100563912 |
| 20106259 | 20087160 | 1.7 | 83.6 | 03 | 2018-03-24 | 2018-03-25 | Fluorouracil + Folinic + RT Bossett | 02 | N | NEO-AEGIS TRIAL | 100006513 |
| 20106347 | 20087161 | 1.33 | 82 | 03 | 2016-08-29 | 2016-09-11 | DOXORUBICIN | 02 | N | CISPLATIN + VINORELBINE | 101267204 |
| 20106380 | 20087162 | 1.72 | 75.8 | Palliative (P) | 2018-09-02 | 2018-09-04 | Rituximab | 02 | N | ARISTOTLE TRIAL | 101262797 |
| 20106400 | 20087163 | 1.55 | 62.4 | Adjuvant (A) | 2018-06-20 | 2018-06-27 | ECarboF | 02 | N | ECARBOX | 100735055 |
| 20106458 | 20087166 | 1.78 | 67.9 | Palliative (P) | 2019-09-21 | 2019-10-09 | EOF | 02 | null | NILOTINIB | 101531659 |
| 20106719 | 20087167 | 1.7 | 86.7 | 03 | 2020-01-10 | 2020-01-28 | PLATFORM Trial | 02 | N | EVEROLIMUS | 101267446 |
| 20106721 | 20087168 | 1.7 | 11.9 | Palliative (P) | 2019-12-27 | 2019-12-27 | Fluorouracil + Folinic + RT Bossett | 02 | N | OXALIPLATIN | 100210206 |
| 20106829 | 20087169 | 1.68 | 51.4 | 03 | null | 2018-02-25 | Fluorouracil + Folinic + RT Bossett | 01 | N | EEX | 100609154 |
| 20106930 | 20087170 | 1.87 | 88.7 | Palliative (P) | 2017-06-19 | 2017-06-19 | Bevacizumab + Capecitabine | 01 | N | DOXORUBICIN + OLARATUMAB | 101426233 |
| 20106998 | 20087172 | 1.78 | 79.8 | null | 2019-02-03 | 2019-02-03 | Temozolomide + RT | null | N | MITOMYCIN | 101050316 |
| 20107166 | 20087173 | 1.66 | 68.2 | Adjuvant (A) | 2016-12-12 | 2016-12-12 | Letrozole + Palbociclib | 02 | N | CARBOPLATIN + FLUOROURACIL | 100126691 |
| 20107322 | 20087174 | 1.7 | 73 | Palliative (P) | 2018-09-27 | 2018-09-27 | Capecitabine + Docetaxel | N | N | REGORAFENIB | 101773626 |
| 20107420 | 20087175 | 1.5 | 48.5 | Palliative (P) | 2018-12-08 | 2018-12-15 | BORTEZOMIB + THALIDOMIDE | N | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100403861 |
| 20107491 | 20087176 | 1.67 | 60.2 | Palliative (P) | 2019-06-04 | 2019-06-04 | Irinotecan | N | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101526053 |
| 20107563 | 20087178 | 1.8 | 74.2 | 03 | 2016-09-01 | 2016-09-03 | CHOP R - 21 days | 01 | N | CISPLATIN + FLUOROURACIL + RT | 100101204 |
| 20107700 | 20087179 | null | 55.3 | null | 2016-11-13 | 2016-12-12 | GEMCARBO | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101566200 |
| 20108059 | 20087182 | 1.78 | 103 | 03 | 2017-04-01 | 2017-04-07 | null | 02 | N | CARBOPLATIN + VINORELBINE | 101609991 |
| 20108076 | 20087183 | 1.81 | 72.4 | Adjuvant (A) | null | 2017-01-27 | Letrozole + Palbociclib | 2 | N | MIC | 100182478 |
| 20108154 | 20087184 | 1.61 | 67.1 | Palliative (P) | 2021-07-10 | 2021-07-11 | Paclitaxel 7 day | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100983289 |
| 20108167 | 20087185 | 1.66 | 57 | 03 | 2019-04-27 | 2019-04-27 | Acalabrutinib | 02 | N | IRINOTECAN | 101751301 |
| 20108194 | 20087186 | 1.69 | 53.6 | Palliative (P) | 2017-09-05 | 2017-09-06 | Capecitabine+Cisplatin+Streptozocin | 02 | N | GEMCITABINE + PACLITAXEL | 100473481 |
| 20108324 | 20087187 | 1.67 | 91.85 | null | 2016-08-11 | 2016-08-26 | FCarboSt | 01 | N | MIC | 100691809 |
| 20108356 | 20087188 | 1.71 | 68 | 03 | 2019-01-17 | 2019-01-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | ABIRATERONE | 101409089 |
| 20108362 | 20087189 | null | 7.1 | null | null | 2018-05-20 | SCOPE 2 TRIAL | 02 | N | SCOPE 1 TRIAL | 101013967 |
| 20108402 | 20087190 | 1.69 | 77.8 | Curative (C) | 2019-12-10 | 2019-12-10 | Everolimus 10mg | 2 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101769870 |
| 20108729 | 20087191 | 1.77 | 81.2 | Palliative (P) | 2016-07-05 | 2016-07-07 | ESPAC-4 TRIAL | 02 | N | HYDROXYCARBAMIDE | 101871261 |
| 20108736 | 20087192 | 1.68 | 63.4 | 03 | 2017-09-08 | 2017-09-08 | SCOPE 2 TRIAL | 01 | N | SUNITINIB | 100468534 |
| 20108821 | 20087193 | 1.62 | 82 | Palliative (P) | 2017-07-26 | 2017-07-26 | CVP R | 02 | N | DOXORUBICIN | 101861857 |
| 20108842 | 20087194 | 1.6 | 44.7 | Palliative (P) | 2019-10-11 | 2019-10-29 | Cladribine (subcut) 5 days | null | N | CVD | 100098250 |
| 20108852 | 20087195 | 1.82 | 96 | 03 | 2019-02-02 | 2019-03-01 | ABC-08 Trial | 02 | N | CABAZITAXEL | 100885043 |
| 20108902 | 20087196 | 1.77 | 76.4 | Palliative (P) | 2018-08-29 | 2018-09-11 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | PLATO TRIAL | 100854301 |
| 20108981 | 20087197 | 1.74 | 61 | 03 | 2019-12-04 | 2019-12-05 | ARISTOTLE TRIAL | N | N | SCOPE2 TRIAL | 100584437 |
| 20109097 | 20087198 | 1.68 | 72.4 | Palliative (P) | 2019-08-22 | 2019-10-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | AZACITIDINE | 101277555 |
| 20109183 | 20087200 | 1.7 | 75.2 | 03 | 2015-10-27 | 2015-11-01 | ACTICCA-1 Trial | 02 | Y | BUSULFAN | 100515131 |
| 20109208 | 20087201 | 1.66 | 87 | Palliative (P) | 2019-06-26 | 2019-07-18 | Trifluridine + Tipiracil | null | N | FOXTROT TRIAL | 100147609 |
| 20109254 | 20087203 | 1.7 | 73 | 03 | 2017-12-20 | 2017-12-27 | Rituximab | 02 | N | HYDROXYCARBAMIDE | 101291535 |
| 20109556 | 20087204 | 1.63 | 53.6 | Curative (C) | null | 2018-12-10 | EOF | Y | N | BACILLUS CALMETTE-GUERIN | 101711471 |
| 20109558 | 20087205 | 1.56 | 77.4 | null | 2019-02-26 | 2019-03-06 | Panitumumab | 2 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100127753 |
| 20109605 | 20087206 | 1.71 | 94.2 | Adjuvant (A) | 2021-11-17 | 2021-12-03 | NIVOLUMAB | 2 | N | NIVOLUMAB | 101606715 |
| 20109776 | 20087207 | 0 | 0 | Neo-adjuvant (N) | 2018-12-17 | 2018-12-27 | BCG Intravesical | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100280817 |
| 20109923 | 20087208 | null | 66 | Palliative (P) | 2016-07-20 | 2016-07-21 | EEF or EOF | 02 | null | RITUXIMAB | 101417972 |
| 20110003 | 20087209 | 1.59 | 67.9 | Adjuvant (A) | 2019-11-18 | 2019-12-23 | Hepatoblastoma SR Cisplatin | 02 | N | ACTICCA-1 TRIAL | 100065397 |
| 20110172 | 20087210 | 1.77 | 67.9 | Palliative (P) | null | 2018-02-08 | PEMBROLIZUMAB | 01 | Y | FLUOROURACIL + RT | 100715395 |
| 20110305 | 20087211 | 1.74 | 61 | Neo-adjuvant (N) | 2018-10-08 | 2018-10-17 | EVEROLIMUS | 02 | N | MCX | 101653892 |